Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1H3 | Q13133 | 1/20 | 0.32 |
| ▸ | CDC14B | O60729 | 1/20 | 0.31 |
| ▸ | CDC14A | Q9UNH5 | 1/20 | 0.31 |
| ▸ | PTGES2 | Q9H7Z7 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.31 |
| ▸ | PLA2G2A | P14555 | 2/20 | 0.31 |
| ▸ | PLA2G4A | P47712 | 2/20 | 0.31 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18164786 | 0.84 | SMN1; SMN2 (0.37) | CDC14BCDC14ALMNAL3MBTL1 | |
| SCHEMBL17126317 | 0.84 | ALOX5 (0.40) | PTGES2LMNAGGPS1PLA2G2APLA2G4A | |
| SCHEMBL14295689 | 0.82 | ALOX5 (0.42) | PTGES2LMNAGGPS1PLA2G2APLA2G4A | |
| SCHEMBL24471688 | 0.82 | ALOX5 (0.40) | PTGES2LMNAGGPS1PLA2G2APLA2G4A | |
| SCHEMBL14295685 | 0.82 | ALOX5 (0.40) | PTGES2LMNAGGPS1PLA2G2APLA2G4A | |
| SCHEMBL14295691 | 0.81 | ALOX5 (0.41) | PTGES2LMNAGGPS1PLA2G2APLA2G4A | |
| SCHEMBL14295705 | 0.81 | PLA2G2A (0.39) | PTGES2LMNAL3MBTL1GGPS1PLA2G2A | |
| SCHEMBL24471723 | 0.81 | ALOX5 (0.41) | PTGES2LMNAGGPS1PLA2G2APLA2G4A | |
| SCHEMBL24472295 | 0.81 | ALOX5 (0.41) | PTGES2LMNAGGPS1PLA2G2APLA2G4A | |
| SCHEMBL14295687 | 0.81 | ALOX5 (0.41) | PTGES2LMNAGGPS1PLA2G2APLA2G4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180123048-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2018-05-03 | — | — | US | disclosed |
| WO-2016167491-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC APPARATUS | 덕산네오룩스 주식회사 | 2016-10-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180123048-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF | PIEZO1, OCIAD1, LEF1 | NR1H3 1404/4885CDC14B 4044/4885CDC14A 3725/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.